Construction Materials
Compare Stocks
2 / 10Stock Comparison
AMRZ vs CRH
Revenue, margins, valuation, and 5-year total return — side by side.
Construction Materials
AMRZ vs CRH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Construction Materials | Construction Materials |
| Market Cap | $30.32B | $75.26B |
| Revenue (TTM) | $11.81B | $49.70B |
| Net Income (TTM) | $1.22B | $4.58B |
| Gross Margin | 25.7% | 35.5% |
| Operating Margin | 16.1% | 13.3% |
| Forward P/E | 19.1x | 18.9x |
| Total Debt | $5.91B | $19.70B |
| Cash & Equiv. | $1.92B | $4.10B |
AMRZ vs CRH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| Amrize Ltd (AMRZ) | 100 | 107.9 | +7.9% |
| CRH plc (CRH) | 100 | 122.7 | +22.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMRZ vs CRH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMRZ is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 1.32
- Lower volatility, beta 1.32, Low D/E 44.6%, current ratio 1.64x
- Beta 1.32, current ratio 1.64x
CRH carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 9.0%, EPS growth 9.8%, 3Y rev CAGR 7.2%
- 331.4% 10Y total return vs AMRZ's 3.7%
- 9.0% revenue growth vs AMRZ's 0.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.0% revenue growth vs AMRZ's 0.9% | |
| Value | Lower P/E (18.9x vs 19.1x) | |
| Quality / Margins | 10.3% margin vs CRH's 9.2% | |
| Stability / Safety | Beta 1.32 vs CRH's 1.35, lower leverage | |
| Dividends | 1.1% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +24.3% vs AMRZ's +3.7% | |
| Efficiency (ROA) | 8.9% ROA vs AMRZ's 5.0%, ROIC 10.7% vs 9.2% |
AMRZ vs CRH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AMRZ vs CRH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — AMRZ and CRH each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CRH is the larger business by revenue, generating $49.7B annually — 4.2x AMRZ's $11.8B. Profitability is closely matched — net margins range from 10.3% (AMRZ) to 9.2% (CRH). On growth, CRH holds the edge at +170.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $11.8B | $49.7B |
| EBITDAEarnings before interest/tax | $2.8B | $9.6B |
| Net IncomeAfter-tax profit | $1.2B | $4.6B |
| Free Cash FlowCash after capex | $1.4B | $2.9B |
| Gross MarginGross profit ÷ Revenue | +25.7% | +35.5% |
| Operating MarginEBIT ÷ Revenue | +16.1% | +13.3% |
| Net MarginNet income ÷ Revenue | +10.3% | +9.2% |
| FCF MarginFCF ÷ Revenue | +12.0% | +5.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.4% | +170.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -34.9% | +2.1% |
Valuation Metrics
CRH leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 20.4x trailing earnings, CRH trades at a 18% valuation discount to AMRZ's 25.0x P/E. On an enterprise value basis, CRH's 12.1x EV/EBITDA is more attractive than AMRZ's 12.2x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $30.3B | $75.3B |
| Enterprise ValueMkt cap + debt − cash | $34.3B | $90.9B |
| Trailing P/EPrice ÷ TTM EPS | 24.99x | 20.44x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.07x | 18.88x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.66x |
| EV / EBITDAEnterprise value multiple | 12.16x | 12.15x |
| Price / SalesMarket cap ÷ Revenue | 2.57x | 2.01x |
| Price / BookPrice ÷ Book value/share | 2.23x | 2.99x |
| Price / FCFMarket cap ÷ FCF | 21.35x | 29.85x |
Profitability & Efficiency
CRH leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CRH delivers a 20.6% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $9 for AMRZ. AMRZ carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to CRH's 0.77x. On the Piotroski fundamental quality scale (0–9), CRH scores 6/9 vs AMRZ's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.2% | +20.6% |
| ROA (TTM)Return on assets | +5.0% | +8.9% |
| ROICReturn on invested capital | +9.2% | +10.7% |
| ROCEReturn on capital employed | +8.9% | +12.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.45x | 0.77x |
| Net DebtTotal debt minus cash | $4.0B | $15.6B |
| Cash & Equiv.Liquid assets | $1.9B | $4.1B |
| Total DebtShort + long-term debt | $5.9B | $19.7B |
| Interest CoverageEBIT ÷ Interest expense | 5.23x | 6.20x |
Total Returns (Dividends Reinvested)
CRH leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRH five years ago would be worth $23,669 today (with dividends reinvested), compared to $10,369 for AMRZ. Over the past 12 months, CRH leads with a +24.3% total return vs AMRZ's +3.7%. The 3-year compound annual growth rate (CAGR) favors CRH at 33.5% vs AMRZ's 1.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -2.7% | -10.6% |
| 1-Year ReturnPast 12 months | +3.7% | +24.3% |
| 3-Year ReturnCumulative with dividends | +3.7% | +137.9% |
| 5-Year ReturnCumulative with dividends | +3.7% | +136.7% |
| 10-Year ReturnCumulative with dividends | +3.7% | +331.4% |
| CAGR (3Y)Annualised 3-year return | +1.2% | +33.5% |
Risk & Volatility
Evenly matched — AMRZ and CRH each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMRZ is the less volatile stock with a 1.32 beta — it tends to amplify market swings less than CRH's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CRH currently trades 85.6% from its 52-week high vs AMRZ's 81.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.32x | 1.35x |
| 52-Week HighHighest price in past year | $65.94 | $131.55 |
| 52-Week LowLowest price in past year | $44.12 | $86.83 |
| % of 52W HighCurrent price vs 52-week peak | +81.1% | +85.6% |
| RSI (14)Momentum oscillator 0–100 | 46.7 | 52.0 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 4.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates AMRZ as "Buy" and CRH as "Buy". Consensus price targets imply 23.6% upside for AMRZ (target: $66) vs 20.4% for CRH (target: $136). CRH is the only dividend payer here at 1.11% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $66.11 | $135.60 |
| # AnalystsCovering analysts | 7 | 20 |
| Dividend YieldAnnual dividend ÷ price | — | +1.1% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $1.25 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.6% |
CRH leads in 3 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 2 categories are tied.
AMRZ vs CRH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AMRZ or CRH a better buy right now?
For growth investors, CRH plc (CRH) is the stronger pick with 9.
0% revenue growth year-over-year, versus 0. 9% for Amrize Ltd (AMRZ). CRH plc (CRH) offers the better valuation at 20. 4x trailing P/E (18. 9x forward), making it the more compelling value choice. Analysts rate Amrize Ltd (AMRZ) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMRZ or CRH?
On trailing P/E, CRH plc (CRH) is the cheapest at 20.
4x versus Amrize Ltd at 25. 0x. On forward P/E, CRH plc is actually cheaper at 18. 9x.
03Which is the better long-term investment — AMRZ or CRH?
Over the past 5 years, CRH plc (CRH) delivered a total return of +136.
7%, compared to +3. 7% for Amrize Ltd (AMRZ). Over 10 years, the gap is even starker: CRH returned +331. 4% versus AMRZ's +3. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMRZ or CRH?
By beta (market sensitivity over 5 years), Amrize Ltd (AMRZ) is the lower-risk stock at 1.
32β versus CRH plc's 1. 35β — meaning CRH is approximately 2% more volatile than AMRZ relative to the S&P 500. On balance sheet safety, Amrize Ltd (AMRZ) carries a lower debt/equity ratio of 45% versus 77% for CRH plc — giving it more financial flexibility in a downturn.
05Which is growing faster — AMRZ or CRH?
By revenue growth (latest reported year), CRH plc (CRH) is pulling ahead at 9.
0% versus 0. 9% for Amrize Ltd (AMRZ). On earnings-per-share growth, the picture is similar: CRH plc grew EPS 9. 8% year-over-year, compared to -7. 0% for Amrize Ltd. Over a 3-year CAGR, CRH leads at 7. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMRZ or CRH?
Amrize Ltd (AMRZ) is the more profitable company, earning 10.
0% net margin versus 10. 0% for CRH plc — meaning it keeps 10. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMRZ leads at 16. 1% versus 14. 2% for CRH. At the gross margin level — before operating expenses — CRH leads at 36. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMRZ or CRH more undervalued right now?
On forward earnings alone, CRH plc (CRH) trades at 18.
9x forward P/E versus 19. 1x for Amrize Ltd — 0. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMRZ: 23. 6% to $66. 11.
08Which pays a better dividend — AMRZ or CRH?
In this comparison, CRH (1.
1% yield) pays a dividend. AMRZ does not pay a meaningful dividend and should not be held primarily for income.
09Is AMRZ or CRH better for a retirement portfolio?
For long-horizon retirement investors, CRH plc (CRH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.
1% yield, +331. 4% 10Y return). Both have compounded well over 10 years (CRH: +331. 4%, AMRZ: +3. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMRZ and CRH?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
CRH pays a dividend while AMRZ does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.